within Pharmacolibrary.Drugs.ATC.D;

model D06AX05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Bacitracin is a polypeptide antibiotic primarily used for topical treatment of superficial skin infections caused by Gram-positive bacteria. It is not typically used systemically due to nephrotoxicity and poor absorption from the gastrointestinal tract. Bacitracin is approved for topical use and as an ingredient in some ophthalmic and otic preparations.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic estimates for topical or systemic use in humans are not available in published literature. Bacitracin is poorly absorbed orally; thus, systemic pharmacokinetic parameters are not clinically relevant and usually not reported. The following parameters are rough estimates based on its physicochemical properties and known lack of systemic absorption.</p><h4>References</h4><ol><li><p>Guaguere, E (1996). Topical treatment of canine and feline pyoderma. <i>Veterinary dermatology</i> 7(3) 145–151. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-3164.1996.tb00239.x&quot;>10.1111/j.1365-3164.1996.tb00239.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34644989/&quot;>https://pubmed.ncbi.nlm.nih.gov/34644989</a></p></li><li><p>Robert, PY, &amp; Adenis, JP (2001). Comparative review of topical ophthalmic antibacterial preparations. <i>Drugs</i> 61(2) 175–185. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200161020-00003&quot;>10.2165/00003495-200161020-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11270936/&quot;>https://pubmed.ncbi.nlm.nih.gov/11270936</a></p></li><li><p>Gul, R, et al., &amp; Ali, MN (2023). An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems. <i>Journal of biomaterials applications</i> 37(10) 1699–1715. DOI:<a href=&quot;https://doi.org/10.1177/08853282231160212&quot;>10.1177/08853282231160212</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36977474/&quot;>https://pubmed.ncbi.nlm.nih.gov/36977474</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D06AX05;
